Ultima-Ipamorelin 2mg

Ipamorelin is an intriguing new finding in muscle growth that is gaining significant attention within the bodybuilding community. Similar to the GHRP-6 peptide (growth hormone releasing hexapeptide), it is a synthetic peptide known for its potent Growth Hormone releasing characteristics. These GH releasing abilities are particularly appealing to athletes and bodybuilders, as they can greatly enhance muscle gain and accelerate fat loss.

Athletes usually administer Ipamorelin at doses ranging from 200mcg to 300mcg, two to three times a day, using a small insulin needle for injection. They often begin with the lower dosage due to potential side effects, including headaches or sensations resembling a head-rush. Ipamorelin can be taken at any time, but ingesting it approximately 30-45 minutes prior to a workout seems optimal due to the surge in Growth Hormone (GH) it induces, promoting maximum growth.

Research on Ipamorelin's effects on bone growth, body weight, and GH release has yielded some intriguing findings.

In one study, participants were given various doses over 15 days to observe their responses.

The results indicated a clear and dose-dependent increase in body weight; however, the treatment group did not exhibit any changes in total IGF-I levels. Additionally, there were no significant changes in serum markers for bone development. For instance, the cell count in the wide section of the tibia (the shinbone) remained relatively stable. This is a positive outcome, suggesting that muscle growth occurs with a reduced risk of bone or cartilage deformities.

The pituitary's response to a high intravenous dose of Ipamorelin revealed that plasma GH levels significantly decreased, while levels remained unchanged after a similar dose of GHRH. This is a favorable indication, as it implies that Ipamorelin may not suppress the body's natural GH production, further underscoring its role as a selective GH releaser.